TWD 19.45
(-2.26%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 270.37 Million TWD | -66.34% |
2022 | 803.26 Million TWD | -15.56% |
2021 | 951.25 Million TWD | -0.8% |
2020 | 958.95 Million TWD | -34.08% |
2019 | 1.45 Billion TWD | 32.48% |
2018 | 1.09 Billion TWD | 16.22% |
2017 | 944.88 Million TWD | 40.93% |
2016 | 670.45 Million TWD | -47.33% |
2015 | 1.27 Billion TWD | -3.86% |
2014 | 1.32 Billion TWD | 175.38% |
2013 | 480.78 Million TWD | -33.83% |
2012 | 726.59 Million TWD | 13.82% |
2011 | 638.34 Million TWD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q1 | 279.81 Million TWD | 3.49% |
2024 Q2 | 277.51 Million TWD | -0.82% |
2023 Q3 | 268.65 Million TWD | -1.09% |
2023 Q1 | 801.59 Million TWD | -0.21% |
2023 Q2 | 271.62 Million TWD | -66.11% |
2023 FY | 270.37 Million TWD | -66.34% |
2023 Q4 | 270.37 Million TWD | 0.64% |
2022 Q2 | 958.61 Million TWD | -0.16% |
2022 Q3 | 800.74 Million TWD | -16.47% |
2022 Q4 | 803.26 Million TWD | 0.32% |
2022 Q1 | 960.18 Million TWD | 0.94% |
2022 FY | 803.26 Million TWD | -15.56% |
2021 Q3 | 982.83 Million TWD | 3.03% |
2021 Q1 | 955.29 Million TWD | -0.38% |
2021 Q2 | 953.88 Million TWD | -0.15% |
2021 FY | 951.25 Million TWD | -0.8% |
2021 Q4 | 951.25 Million TWD | -3.21% |
2020 Q1 | 1.54 Billion TWD | 6.03% |
2020 Q2 | 1.45 Billion TWD | -5.97% |
2020 Q3 | 1.01 Billion TWD | -30.07% |
2020 FY | 958.95 Million TWD | -34.08% |
2020 Q4 | 958.95 Million TWD | -5.47% |
2019 Q2 | 950.23 Million TWD | -42.5% |
2019 Q4 | 1.45 Billion TWD | -7.33% |
2019 FY | 1.45 Billion TWD | 32.48% |
2019 Q1 | 1.65 Billion TWD | 50.48% |
2019 Q3 | 1.56 Billion TWD | 65.22% |
2018 Q1 | 958.5 Million TWD | 1.44% |
2018 FY | 1.09 Billion TWD | 16.22% |
2018 Q4 | 1.09 Billion TWD | -9.03% |
2018 Q3 | 1.2 Billion TWD | 12.65% |
2018 Q2 | 1.07 Billion TWD | 11.79% |
2017 Q3 | 1 Billion TWD | -32.9% |
2017 FY | 944.88 Million TWD | 40.93% |
2017 Q4 | 944.88 Million TWD | -6.1% |
2017 Q1 | 919.86 Million TWD | 37.2% |
2017 Q2 | 1.49 Billion TWD | 63.04% |
2016 Q4 | 670.45 Million TWD | -7.42% |
2016 Q3 | 724.17 Million TWD | 13.3% |
2016 Q2 | 639.18 Million TWD | -51.15% |
2016 Q1 | 1.3 Billion TWD | 2.8% |
2016 FY | 670.45 Million TWD | -47.33% |
2015 Q3 | 1.33 Billion TWD | 5.61% |
2015 Q4 | 1.27 Billion TWD | -4.38% |
2015 Q2 | 1.26 Billion TWD | -14.59% |
2015 FY | 1.27 Billion TWD | -3.86% |
2015 Q1 | 1.47 Billion TWD | 11.47% |
2014 Q3 | 1.39 Billion TWD | 23.63% |
2014 Q1 | - TWD | -100.0% |
2014 Q2 | 1.13 Billion TWD | 0.0% |
2014 FY | 1.32 Billion TWD | 175.38% |
2014 Q4 | 1.32 Billion TWD | -5.27% |
2013 Q4 | 480.78 Million TWD | 0.0% |
2013 FY | 480.78 Million TWD | -33.83% |
2013 Q1 | 898.12 Million TWD | 23.61% |
2013 Q2 | 888.73 Million TWD | -1.05% |
2012 Q2 | 815.7 Million TWD | 0.0% |
2012 FY | 726.59 Million TWD | 13.82% |
2012 Q4 | 726.59 Million TWD | 0.0% |
2012 Q3 | - TWD | -100.0% |
2011 Q4 | 638.34 Million TWD | 0.0% |
2011 FY | 638.34 Million TWD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Bio Preventive Medicine Corp. | 113.44 Million TWD | -138.328% |
Genomics BioSci & Tech. Co.,Ltd. | 283.61 Million TWD | 4.667% |
Advagene Biopharma Co., Ltd. | 870 Thousand TWD | -30977.701% |
Taiwan Bio Therapeutics Co., Ltd | 268.62 Million TWD | -0.653% |
NaviFUS Corp. | 32.69 Million TWD | -727.015% |
G&E Herbal Biotechnology Co., Ltd. | 5.43 Million TWD | -4878.383% |
TaiRx, Inc. | 12.28 Million TWD | -2100.684% |
Sinew Pharma Inc. | 6.46 Million TWD | -4082.797% |
Lin BioScience, Inc. | 42.87 Million TWD | -530.644% |
TaiwanJ Pharmaceuticals Co., Ltd. | 1.17 Million TWD | -22989.325% |
Lumosa Therapeutics Co., Ltd. | 12.61 Million TWD | -2044.14% |
Anti-Microbial Savior BioteQ Co., Ltd | 1.38 Million TWD | -19449.964% |
SYN-TECH Chem. & Pharm. Co., Ltd. | 402.75 Million TWD | 32.868% |
AP Biosciences Inc | 82.07 Million TWD | -229.409% |
Sunmax Biotechnology Co., Ltd. | 174.08 Million TWD | -55.31% |
RBC Bioscience Corporation | 487.36 Million TWD | 44.523% |
Syngen Biotech Co.,Ltd. | 681.76 Million TWD | 60.342% |
EirGenix Inc. | 465.16 Million TWD | 41.875% |
Enimmune corporation | 45.73 Million TWD | -491.193% |
Lukas Biomedical Inc. | 82.55 Million TWD | -227.51% |
BRIM Biotechnology, Inc. | 3.59 Million TWD | -7427.171% |
3D Global Biotech Inc. | 10.37 Million TWD | -2505.029% |
TaiMed Biologics Inc. | 750.85 Million TWD | 63.991% |
Mycenax Biotech Inc. | 726.27 Million TWD | 62.772% |
TCI GENE Inc. | 6.79 Million TWD | -3879.043% |
SynCore Biotechnology Co.,Ltd | 2.11 Million TWD | -12689.782% |
Oneness Biotech Co., Ltd. | 397.95 Million TWD | 32.058% |
Eusol Biotech Co.,Ltd. | 4.35 Million TWD | -6109.83% |
Feng Chi Biotech Corp. | 10.79 Million TWD | -2403.945% |
NeoCore Technology Co., Ltd. | 96.89 Million TWD | -179.052% |
TWi Biotechnology, Inc. | 7.97 Million TWD | -3291.996% |
Neith Corporation | 3.54 Million TWD | -7535.583% |
Sunny Pharmtech Inc. | 391.42 Million TWD | 30.926% |
VBI | - TWD | -Infinity% |
Ever Supreme Bio Technology Co., Ltd | 5.89 Million TWD | -4484.198% |
GeneReach Biotechnology Corp. | 257.03 Million TWD | -5.189% |
Shine-On BioMedical Co.,Ltd. | 538 Thousand TWD | -50155.762% |
CHO Pharma, Inc. | - TWD | -Infinity% |
Andros Pharmaceuticals Co.,Ltd | 27.12 Million TWD | -896.925% |
MegaPro Biomedical Co., Ltd | 8.31 Million TWD | -3150.493% |
Visgeneer Inc. | 158.6 Million TWD | -70.47% |
Greenyn Biotechnology Co., Ltd | 196.13 Million TWD | -37.853% |
BioLASCO Taiwan Co., Ltd. | 58.2 Million TWD | -364.516% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | 417.01 Million TWD | 35.164% |
Sagittarius Life Science Corp | 13.32 Million TWD | -1929.393% |
BioGend Therapeutics Co., Ltd. | 13.09 Million TWD | -1965.2% |
GlycoNex Incorporation | 900 Thousand TWD | -29941.778% |
Medigen Biotechnology Corp. | 2.91 Billion TWD | 90.714% |
Pharmosa Biopharm Inc. | 144.36 Million TWD | -87.281% |
PharmaEngine, Inc. | 14.8 Million TWD | -1725.755% |
Intech Biopharm Corporation | 1.43 Billion TWD | 81.159% |
Taiwan Advance Bio-Pharmaceutical Inc. | 320.13 Million TWD | 15.542% |
BiOptic Inc. | 93.19 Million TWD | -190.109% |
TaiGen Biopharmaceuticals Holdings Limited | 74.68 Million TWD | -262.012% |
Senhwa Biosciences, Inc. | 9.6 Million TWD | -2716.123% |
NatureWise Biotech & Medicals Corporation | 10.68 Million TWD | -2431.136% |
OBI Pharma, Inc. | 501.05 Million TWD | 46.038% |
Great Novel Therapeutics Biotech & Medicals | 14.37 Million TWD | -1780.877% |
Level Biotechnology Inc. | 13.5 Million TWD | -1902.489% |
Medigen Vaccine Biologics Corporation | 1.97 Billion TWD | 86.306% |
Meribank Biotech Co., Ltd | 34.03 Million TWD | -694.312% |
Acepodia, Inc. | 273.81 Million TWD | 1.255% |
Caliway Biopharmaceuticals Co., Ltd. | 20.45 Million TWD | -1221.615% |